FDA advises on drug naming; Novavax seeks new flu vax partner for Spain;

> New FDA guidance advises drugmakers on the creation of proprietary drug names to minimize medication errors. Guidance

> Novavax has discontinued its deal with ROVI Pharmaceuticals to develop the former's influenza vaccine for Spain. Release

> As the camera film business continues its decline, Kodak is using its manufacturing operations and expertise to produce gels for the pharma industry as well as inks and dyes for personal-care products. Article

> Regis Technologies of Morton Grove, IL, has passed the FDA's pre-approval inspection for its manufacture of the active ingredient in multiple sclerosis drug Ampyra, approved last month. Release

> Sweden's Medical Products Agency is proposing that an environmental certification for pharmaceutical production facilities be introduced into Good Manufacturing Practice requirements. Article

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)